Eyenovia Management
Management criteria checks 1/4
Eyenovia's CEO is Michael Rowe, appointed in Jul 2018, has a tenure of 5.75 years. total yearly compensation is $1.33M, comprised of 38.4% salary and 61.6% bonuses, including company stock and options. directly owns 0.065% of the company’s shares, worth $17.45K. The average tenure of the management team and the board of directors is 5.8 years and 2.2 years respectively.
Key information
Michael Rowe
Chief executive officer
US$1.3m
Total compensation
CEO salary percentage | 38.4% |
CEO tenure | 5.8yrs |
CEO ownership | 0.06% |
Management average tenure | 5.8yrs |
Board average tenure | 2.2yrs |
Recent management updates
Recent updates
Is Eyenovia (NASDAQ:EYEN) Weighed On By Its Debt Load?
Jan 30Is Eyenovia (NASDAQ:EYEN) Using Debt In A Risky Way?
Oct 14Is Eyenovia (NASDAQ:EYEN) Using Debt Sensibly?
Jun 27Does Eyenovia (NASDAQ:EYEN) Have A Healthy Balance Sheet?
Oct 25Eyenovia gains as H.C. Wainwright initiates with Buy on pipeline potential
Oct 05Eyenovia names Michael Rowe as new CEO
Jul 27New Forecasts: Here's What One Analyst Thinks The Future Holds For Eyenovia, Inc. (NASDAQ:EYEN)
Apr 03Earnings Beat: Eyenovia, Inc. (NASDAQ:EYEN) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Mar 31Eyenovia: I Can See You Better - Now
Mar 04Eyenovia: Reassessing After The FDA Moves The Goalposts
Nov 23Eyenovia: FDA Setback Is Big Opportunity For Investors
Nov 08Eyenovia: Can You See Me Now?
Oct 21Is Eyenovia (NASDAQ:EYEN) A Risky Investment?
Sep 16Eyenovia updates on late-stage program for presbyopia therapy
Jun 15Eyenovia: Recent MicroLine Data, October MydCombi PDUFA Date Bode Well For Value Creation
Jun 02Eyenovia announces new $25M credit facility with Silicon Valley Bank
May 10Stuart Grant Just Bought A Sprinkling of Shares In Eyenovia, Inc. (NASDAQ:EYEN)
Mar 09CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -US$27m |
Sep 30 2023 | n/a | n/a | -US$25m |
Jun 30 2023 | n/a | n/a | -US$25m |
Mar 31 2023 | n/a | n/a | -US$26m |
Dec 31 2022 | US$1m | US$512k | -US$28m |
Sep 30 2022 | n/a | n/a | -US$19m |
Jun 30 2022 | n/a | n/a | -US$17m |
Mar 31 2022 | n/a | n/a | -US$15m |
Dec 31 2021 | US$1m | US$360k | -US$13m |
Sep 30 2021 | n/a | n/a | -US$20m |
Jun 30 2021 | n/a | n/a | -US$19m |
Mar 31 2021 | n/a | n/a | -US$20m |
Dec 31 2020 | US$665k | US$275k | -US$20m |
Sep 30 2020 | n/a | n/a | -US$21m |
Jun 30 2020 | n/a | n/a | -US$20m |
Mar 31 2020 | n/a | n/a | -US$21m |
Dec 31 2019 | US$482k | US$275k | -US$21m |
Compensation vs Market: Michael's total compensation ($USD1.33M) is above average for companies of similar size in the US market ($USD673.36K).
Compensation vs Earnings: Michael's compensation has increased whilst the company is unprofitable.
CEO
Michael Rowe (61 yo)
5.8yrs
Tenure
US$1,333,510
Compensation
Mr. Michael M. Rowe serves as Chief Executive Officer at Eyenovia, Inc. since August 01, 2022 and is its Director since August 2022. He had been Chief Operating Officer of Eyenovia, Inc. since January 31,...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder & Executive Chairman | 10.1yrs | US$1.03m | 0.66% $ 178.7k | |
CEO & Director | 5.8yrs | US$1.33m | 0.065% $ 17.5k | |
CFO & Secretary | 6.3yrs | US$651.29k | 0.016% $ 4.2k | |
COO & Corporate VP | 1.3yrs | no data | 0.0049% $ 1.3k | |
Investor Contact | no data | no data | no data |
5.8yrs
Average Tenure
54.5yo
Average Age
Experienced Management: EYEN's management team is seasoned and experienced (5.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder & Executive Chairman | 10.1yrs | US$1.03m | 0.66% $ 178.7k | |
CEO & Director | 1.7yrs | US$1.33m | 0.065% $ 17.5k | |
Independent Director | 6.1yrs | US$148.70k | 0.15% $ 41.1k | |
Independent Director | less than a year | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 1.8yrs | US$109.30k | 0.11% $ 30.7k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 1.8yrs | US$100.55k | 0.040% $ 10.7k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
Independent Director | 2.2yrs | US$138.39k | 0.050% $ 13.5k |
2.2yrs
Average Tenure
61yo
Average Age
Experienced Board: EYEN's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.